Press Releases

Nov 15, 2018 Precipio Announces Third Quarter 2018 Corporate Update Call for Shareholders
Nov 14, 2018 Webinar to Highlight Technology Underlying Precipio’s ICE COLD-PCR on November 20, 2018
Nov 01, 2018 Precipio and PerkinElmer Collaborate to Provide Solutions for Liquid Biopsy Testing Workflows
Oct 23, 2018 Precipio Expands ICE COLD-PCR™ Menu For Breast, Colon and Endometrial Cancers
Oct 18, 2018 Innovation Behind Precipio's ICE-COLD PCR™ Platform Spotlighted in Media
Oct 16, 2018 Precipio Announces Third Quarter 2018 Revenues Estimated at 2.4 Times Year-over-Year Q3-2017
Oct 03, 2018 Precipio Launches HemeScreen™, a Disruptive, Proprietary Molecular Test for Hematologic Cancers
Sep 27, 2018 Precipio Granted 180 Day NASDAQ Extension to Regain Compliance
Sep 20, 2018 Precipio Expands ICE-COLD PCR™ Lung Cancer Mutation Detection Offering
Aug 22, 2018 Precipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter Results
Aug 17, 2018 Precipio Announces Second Quarter 2018 Financial Results and Provides Corporate Update
Aug 09, 2018 Precipio Appoints New Board Member to Replace Departing Director
Jul 18, 2018 Precipio Announces 213% Year-over-Year Revenue Growth in Preliminary Q2-2018 Results
Jun 26, 2018 Precipio and Nucleai Partner to Develop Artificial Intelligence-Powered Hemepath Solution
Jun 19, 2018 Precipio Updates Commercial Pipeline for its ICE-COLD PCR™ Liquid Biopsy Technology
Jun 15, 2018 Precipio Inc. Announces Adjournment of Annual Meeting of Shareholders
Jun 14, 2018 Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018
Jun 12, 2018 Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018
Jun 06, 2018 Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology
May 24, 2018 Precipio Launches Liquid Biopsy DNA Enrichment Sales in Europe with First Order
May 22, 2018 Potential Sequential Revenue Run-Rate Growth of 30% over Q1, based on Preliminary April Results
May 17, 2018 Precipio Launches ICE COLD-PCR™ Liquid Biopsy Kit for Pancreatic Cancer
May 14, 2018 Precipio Announces Preliminary Q1 2018 Year-over-Year Revenue Increase of 286%
Apr 26, 2018 Precipio Announces Participation Details for Upcoming Shareholder Conference Call
Apr 23, 2018 Precipio Completes a $3M Convertible Debt Facility
Apr 18, 2018 Precipio in Strategic Partnership Discussions for Proprietary Cytogenetics Media IV-Cell
Apr 17, 2018 Precipio Releases its 2017 10-K, Files a form S-1, and hosts Fourth Quarter and Full Year Update Call
Apr 11, 2018 Precipio Launches ICE COLD-PCR™ Research Access Program for Cancer Centers
Apr 03, 2018 Important JAMA Article Underscores Superiority of Precipio’s Liquid Biopsy Core Technology
Mar 28, 2018 Precipio Files Patent for Non-Invasive Cell Capture Device For Gynecological Cancer Detection
Mar 26, 2018 Precipio Enters India Liquid Biopsy Market with Adoption by Leading Laboratory
Mar 22, 2018 Precipio Restructures Capitalization Table
Mar 20, 2018 Precipio Integrates Cost Reducing and Fast Turnaround "High Resolution Melt" into Liquid Biopsy Platform
Mar 13, 2018 Precipio Settles Lawsuit with Crede Capital
Feb 22, 2018 Key Measure of Precipio’s Pathology Sales Growth 4X Prior Quarter
Feb 15, 2018 Precipio Launches Unique Lung Cancer Monitoring Test for Therapy Resistance
Feb 09, 2018 Precipio Announces Q4 2017 Revenue at 350% of Previous Quarter
Feb 06, 2018 Precipio Enters Japanese Liquid Biopsy Market with First Hospital Sale
Jan 22, 2018 Precipio Commences Validation Study of Proprietary IV-Cell Cytogenetics Media at University of Pennsylvania
Jan 16, 2018 Precipio Appoints New Sales VP to Manage Diagnostics Sales Expansion
Jan 10, 2018 Yale Study Demonstrates Four-Fold Superiority of Academic Level Diagnostic Accuracy
View All News Articles